home > news
 > News
 > TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife® Satylia® in Germany
News
29/11/2022

TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife® Satylia® in Germany

TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife® Satylia® in Germany. The novel dietary supplement based on the next-generation probiotic Hafnia alvei HA4597 will be available from January 2023. […]

Access the press release

Our news

News
24/08/2023
Alliance Promotion Microbiote applauds the new legislation securing stool collection in France
> READ
News
03/02/2023
MaaT Pharma Receives U.S. FDA Response
> READ
News
23/01/2024
Focus SoHO et Paquet Pharma
> READ
> See all news